Stock Market News

China’s cancer drugmaker BlissBio considers Hong Kong IPO – Bloomberg

May 16, 2025 - 04:52
 0
China’s cancer drugmaker BlissBio considers Hong Kong IPO – Bloomberg
Read More

Tags:

Previous Article

Paramount’s upcoming Mission: Impossible film lands China release- Bloomberg

Next Article

Japan to release more rice from stockpiles to tackle shortage and rein in prices

Related Posts

7-Eleven commercial paper rating downgraded by Moody's, outlook remains negative

7-Eleven commercial paper rating downgraded by Moody's,...

May 12, 2025  0

Fed officials reconsidering monetary policy approach amid supply shocks

Fed officials reconsidering monetary policy approach am...

May 15, 2025  0

Apimeds Pharmaceuticals starts trading at $4 per share in line with IPO pricing

Apimeds Pharmaceuticals starts trading at $4 per share ...

May 9, 2025  0